SB INVESTMENT ADVISERS (UK) LTD - 31 Dec 2025 SCHEDULE 13G/A Report for Vir Biotechnology, Inc. Common Stock, $0.0001 par value (VIR)

Filing Manager
SB INVESTMENT ADVISERS (UK) LTD
Reporting Manager
SB Investment Advisers (UK) Limited
Security
Vir Biotechnology, Inc. Common Stock, $0.0001 par value
Symbol
VIR
Shares outstanding
139,542,309 shares
Disclosed Ownership
13,116,977 shares
Ownership
9.4%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 17:00:08 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SB Investment Advisers (UK) Limited 9.4% 13,116,977 0 13,116,977 /s/ Amanda Sanchez-Barry Amanda Sanchez-Barry, General Counsel
SoftBank Vision Fund (AIV M1) L.P. 9.4% 13,116,977 0 13,116,977 By: SB Investment Advisers (UK) Limited, its Manager, /s/ Amanda Sanchez-Barry Amanda Sanchez-Barry, General Counsel
SVF Endurance (Cayman) Limited 9.4% 13,116,977 0 13,116,977 /s/ Nilani Perera Nilani Perera, Director